Toshiki Otoda
-
- Diabetes Treatment and Management 4
- Diet, Metabolism, and Disease 2
-
- Chronic Kidney Disease and Diabetes 6
-
- Liver Disease Diagnosis and Treatment 2
-
- Diet and metabolism studies 2
-
- Advanced Glycation End Products research 3
-
- Pancreatic function and diabetes 3
-
- Metabolism, Diabetes, and Cancer 3
Toshiki Otoda
17 papers receiving 234 citations
Peers
Comparison fields: 5 of 62
- Endocrinology, Diabetes and Metabolism 106
- Nephrology 22
- Epidemiology 81
- Physiology 53
- Endocrine and Autonomic Systems 11
Countries citing papers authored by Toshiki Otoda
This map shows the geographic impact of Toshiki Otoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiki Otoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiki Otoda more than expected).
Fields of papers citing papers by Toshiki Otoda
This network shows the impact of papers produced by Toshiki Otoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiki Otoda. The network helps show where Toshiki Otoda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Toshiki Otoda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 5 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 2 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 5 | |
| 14 | Evaluating the Ubiquitin–proteasome System as a Therapeutic Target in Diabetic Kidney Disease | 2018 | 1 |
| 15 | 2016 | 10 | |
| 16 | 2014 | 25 | |
| 17 | 2014 | 19 | |
| 18 | 2013 | 10 | |
| 19 | 2012 | 124 | |
| 20 | 2009 | 11 |
About Toshiki Otoda
Toshiki Otoda is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Clinical Biochemistry, having authored 21 papers that have together received 242 indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (6 papers), Diabetes Treatment and Management (4 papers), Advanced Glycation End Products research (3 papers), Pancreatic function and diabetes (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Liver Disease Diagnosis and Treatment (2 papers), Diet, Metabolism, and Disease (2 papers) and Diet and metabolism studies (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (106 citations), Nephrology (22 citations) and Epidemiology (81 citations). Toshiki Otoda has collaborated with scholars based in Japan. Frequent co-authors include Toshinari Takamura, Yuki Kita, Yumie Takeshita, Shuichi Kaneko, Kenichiro Kato, Hirofumi Misu, Naoto Nagata, Akio Fujimura, Yinhua Ni and Tsuguhito Ota. Their work appears in journals such as Biomedicines, Journal of Diabetes Investigation, BMJ Open Diabetes Research & Care, Heliyon and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.